Clinical indicators of Pneumocystis jiroveci pneumonia (PCP) in South African children infected with the human immunodeficiency virus.
Từ khóa
trừu tượng
BACKGROUND
Pneumocystis pneumonia (PCP) caused by Pneumocystis jiroveci is common in HIV-infected children, producing substantial morbidity and mortality. Initiation of timely, effective therapy depends on clinical identification of children with PCP.
OBJECTIVE
To develop a clinical decision rule to diagnose PCP in HIV-infected children for use where diagnostic resources are limited.
METHODS
Analysis of data collected during a prospective incidence study of the etiology, features, and outcome of HIV-infected children hospitalized with pneumonia.
RESULTS
Four clinical variables were independently associated with a diagnosis of PCP in multivariate analysis: age < 6 months (OR 15.6; 95% CI 2.4-99.8; p = 0.004), respiratory rate > 59 breaths/min (OR 8.1; 95% CI 1.5-53.2; p = 0.018), arterial percentage hemoglobin oxygen saturation (SaO2) < or = 92% (OR 5.1; 95% CI 1.0-26.1; p = 0.052) and absence of history of vomiting (OR 11.2; 95% CI 1.9-68.0; p = 0.008). The sensitivity and specificity of diagnosing PCP with any two or more of these variables were 1.00 (95% CI 0.74-1.00) and 0.49 (95% CI 0.39-0.59), respectively. Diagnosing PCP with three or more of the indicators had a decreased sensitivity of 0.75 (95% CI 0.43-0.95) and increased specificity of 0.90 (95% CI 0.83-0.95).
CONCLUSIONS
Empirical anti-pneumocystis therapy should be considered in HIV-infected infants presenting with tachypnea, hypoxia and absence of vomiting.